BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4827366)

  • 1. Characterization of a phosphoglycerate kinase variant associated with hemolytic anemia.
    Yoshida A; Miwa S
    Am J Hum Genet; 1974 May; 26(3):378-84. PubMed ID: 4827366
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythroenzymopathies and hemolytic anemia: the many faces of inherited variant enzymes.
    Valentine WN; Paglia DE
    J Lab Clin Med; 1990 Jan; 115(1):12-20. PubMed ID: 2405080
    [No Abstract]   [Full Text] [Related]  

  • 3. Phosphoglycerate kinase San Francisco: a new variant associated with hemolytic anemia but not with neuromuscular manifestations.
    Guis MS; Karadsheh N; Mentzer WC
    Am J Hematol; 1987 Jun; 25(2):175-82. PubMed ID: 3605066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cultured lymphoblastoid cells for the study of abnormal enzymes: molecular abnormality of a phosphoglycerate kinase variant associated with hemolytic anemia.
    Fujii H; Chen SH; Akatsuka J; Miwa S; Yoshida A
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2587-90. PubMed ID: 6941312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary hemolytic anemia: association with phosphoglycerate kinase deficiency in erythrocytes and leukocytes.
    Valentine WN; Hsieh HS; Paglia DE; Anderson HM; Baughan MA; Jaffé ER; Garson OM
    Trans Assoc Am Physicians; 1968; 81():49-65. PubMed ID: 5721411
    [No Abstract]   [Full Text] [Related]  

  • 6. [Erythrocyte and leucocyte 3-phosphoglycerate kinase deficiency. Studies of properties of the enzyme, phagocytic activity of the polymorphonuclear leucoytes and a review of the literature].
    Boivin P; Hakim J; Mandereau J; Galand C; Degos F; Schaison G
    Nouv Rev Fr Hematol; 1974; 14(4):495-508. PubMed ID: 4280558
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical consequences of enzyme deficiencies in the erythrocyte.
    Oski FA
    Ann Clin Lab Sci (1971); 1971; 1(2):177-83. PubMed ID: 4263485
    [No Abstract]   [Full Text] [Related]  

  • 8. Human erythrocyte phosphoglycerate kinase deficiency: presence in a deficient patient of a stable variant with lowered catalytic activity.
    Kahn A; Cottreau D; Galand C; Boivin P
    Clin Chim Acta; 1976 May; 69(1):21-8. PubMed ID: 817852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red cell enzyme deficiencies as a cause of hemolytic disorders.
    Valentine WN
    Annu Rev Med; 1972; 23():93-100. PubMed ID: 4268540
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of a phosphoglycerate kinase deficiency variants not associated with hemolytic anemia.
    Krietsch WK; Eber SW; Haas B; Ruppelt W; Kuntz GW
    Am J Hum Genet; 1980 May; 32(3):364-73. PubMed ID: 6770677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical symptoms and biochemical properties of three new glucosephosphate isomerase variants.
    Eber SW; Gahr M; Lakomek M; Prindull G; Schröter W
    Blut; 1986 Jul; 53(1):21-8. PubMed ID: 3719111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic regulation in enzyme-deficient red cells.
    Buc HA; Leroux JP; Garreau H; Marchand JC; Cartier P
    Enzyme; 1974; 18(1):19-36. PubMed ID: 4152958
    [No Abstract]   [Full Text] [Related]  

  • 13. Congenital hemolytic anemias and red cell enzyme deficiencies.
    Oski FA; Stockman JA
    Curr Probl Pediatr; 1973 Dec; 4(2):1-40. PubMed ID: 4272089
    [No Abstract]   [Full Text] [Related]  

  • 14. The Stratton Lecture. Hemolytic anemia and inborn errors of metabolism.
    Valentine WN
    Blood; 1979 Sep; 54(3):549-59. PubMed ID: 572716
    [No Abstract]   [Full Text] [Related]  

  • 15. Phosphoglycerate kinase deficiency due to a novel mutation (c. 1180A>G) manifesting as chronic hemolytic anemia in a Japanese boy.
    Tamai M; Kawano T; Saito R; Sakurai K; Saito Y; Yamada H; Ida H; Akiyama M
    Int J Hematol; 2014 Oct; 100(4):393-7. PubMed ID: 24934115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human phosphoglycerate kinase and inactivation of the X chromosome.
    Deys BF; Grzeschick KH; Grzeschick A; Jaffé ER; Siniscalco M
    Science; 1972 Mar; 175(4025):1002-3. PubMed ID: 5009390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laboratory diagnosis of enzymopenic hemolytic anemia].
    Vetrella M; De Cicco N
    Pediatria (Napoli); 1972; 80(2):186-97. PubMed ID: 4262752
    [No Abstract]   [Full Text] [Related]  

  • 18. Deficiencies associated with Embden-Meyerhof pathway and other metabolic pathways.
    Valentine WN
    Semin Hematol; 1971 Oct; 8(4):348-66. PubMed ID: 4256808
    [No Abstract]   [Full Text] [Related]  

  • 19. [Congenital hemolytic anemia associated with phosphoglycerate kinase deficiency in erythrocytes, polynuclear cells and lymphocytes].
    Cartier P; Habibi B; Leroux JP; Marchand JC
    Nouv Rev Fr Hematol; 1971; 11(4):565-78. PubMed ID: 4257431
    [No Abstract]   [Full Text] [Related]  

  • 20. Red cell aldolase deficiency and hemolytic anemia: a new syndrome.
    Beutler E; Scott S; Bishop A; Margolis N; Matsumoto F; Kuhl W
    Trans Assoc Am Physicians; 1973; 86():154-66. PubMed ID: 4788792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.